Early Stage ER+ Breast Cancer 2010 - Sparing Chemotherapy Using Multigene Assays

Kathy S. Albain, M.D., Professor of Medicine, Loyola University Chicago Stritch School of Medicine, Director, Breast Clinical Research and Thoracic Oncology Programs
Loyola University Chicago Stritch School of Medicine, Chicago, IL
Double click image to enlarge
Set as Cover Image
Chapter Description:

Previous Image Next Image
Image 1
Image 2
Image 3
Image 4
Image 5
Image 6
Image 7
Image 8
Image 9
Image 10
Image 11
Image 12
Image 13
Image 14
Image 15
Image 16
Image 17
Image 18
Image 19
Image 20
Image 21
Image 22
Image 23
Image 24
Image 25
Image 26
Image 27
Image 28
Image 29
Image 30
Image 31
Image 32
Image 33
Image 34
Image 35
Image 36
Image 37
Image 38
Image 39
Image 40
Image 41
Image 42
Image 43
Image 44
Image 45
Image 46
Image 47
Image 48
Image 49
Image 50
Image 51
Image 52
Image 53
Image 54
Image 55
Image 56
Image 57
Image 58
Image 59
Image 60
Image 61
 
  • Comments
  • Description
   
Sign up to Add Comment!
 
Characters Left :
  
    Brief Description
 
In this presentation Dr. Kathy Albain speaks in depth about sparing chemotherapy using multigene assays in regards to early stage ER+ breast cancer.
 
    Full Description
 
 
    Citation
 
 
    Abstract
 
 
    Introduction
 
 
    Results
    Discussions
 
 
    Material Methods
 
 
    References
 
 
 
 
Stats
 
Publish date Views Ref#
Jul 21, 2010 1109 VA:07:20:4697:2010
 
Rating
   
 
Your rating: None
 
Embed Code
 
Files
 
 
 

Contact Us | Investors | About VeoMed | News | Help

Copyright ® VeoMed.com 2006-2007 All Rights Reserved    Privacy Policy | Terms of Use

Quick Links
Open Access
My Dashboard
Login
Signup